Trial Now Recruiting: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System (NCT01143454)
WHY IT MATTERS
This large-scale study is actively recruiting and may help identify new risk factors for heart disease in people with rare metabolic, inflammatory, and genetic conditions like Li-Fraumeni Syndrome and cardiomyopathy.
Researchers at the National Heart, Lung, and Blood Institute are looking for 5,000 people who have or might have diseases that affect their heart, blood vessels, or metabolism. Participants will have blood tests and heart function tests tailored to their specific condition. Both people with these conditions and healthy people can join to help scientists understand why some people develop heart disease.
NCT ID: NCT01143454 Status: RECRUITING Conditions: Metabolic Disease, Obesity, Li-Fraumeni Syndrome, Cardiomyopathy, Atherosclerosis, Inflammatory Disease Enrollment: 5000 Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Summary: Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the heart, blood vessels and lung function. The testing is tailored to the individual and/or condition bein
YOU CAN ACT ON THIS
If you have a metabolic disease, inflammatory condition, genetic syndrome, or cardiomyopathy, check the clinicaltrials.gov website (NCT01143454) to see if you meet eligibility criteria and find participating sites near you.